Phase i study of ceralasertib (AZD6738), a novel DNA damage repair agent, in combination with weekly paclitaxel in refractory cancer

  • Seung Tae Kim
  • , Simon A. Smith
  • , Peter Mortimer
  • , Arsene Bienvenu Loembé
  • , Heejin Cho
  • , Kyoung Mee HKim
  • , Claire Smith
  • , Sophie Willis
  • , Itziar Irurzun-Arana
  • , Alienor Berges
  • , Jung Yong Hong
  • , Se Hoon Park
  • , Joon Oh Park
  • , Young Suk Park
  • , Ho Yeong Lim
  • , Won Ki Kang
  • , Iwanka Kozarewa
  • , Andrew J. Pierce
  • , Emma Dean
  • , Jeeyun Lee

Research output: Contribution to journalArticlepeer-review

71 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i study of ceralasertib (AZD6738), a novel DNA damage repair agent, in combination with weekly paclitaxel in refractory cancer'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science